Skip to main content
With Peter A. Schneider on Muck Rack

With Peter A. Schneider

As seen in: Endovascular Today
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with With Peter A.

Contact With Peter A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

From Concept to First Human Use: Inside the Serranator® SONIC IVL System

|
By Paul Wilson, With Peter A. Schneider
| Endovascular Today Verified
Peter A. Schneider, MD Division of Vascular and Endovascular Surgery University of California San Francisco San Francisco, California Paul Wilson Chief Commercial Officer Cagent Vascular Wayne, Pennsylvania Cagent Vascular recently announced two milestones: the successful completion of first-in-human (FIH) cases with the Serranator® SONIC Intravascular Lithotripsy (IVL) System (Cagent Vascular) and the closing of an oversubscribed $41 million Series D financing.
Open in Who Shared Issue with article?
See all 1 articles